GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » YoY Rev. per Sh. Growth

LOBEF (Lobe Sciences) YoY Rev. per Sh. Growth : 0.00% (As of May. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Lobe Sciences's YoY Rev. per Sh. Growth for the quarter that ended in May. 2024 was 0.00%.

Lobe Sciences's Revenue per Share for the three months ended in May. 2024 was $0.00.

Lobe Sciences YoY Rev. per Sh. Growth Historical Data

The historical data trend for Lobe Sciences's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences YoY Rev. per Sh. Growth Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -100.00 - - -

Lobe Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lobe Sciences YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Lobe Sciences's YoY Rev. per Sh. Growth for the fiscal year that ended in Aug. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Aug. 2023 )
=(Revenue per Share (A: Aug. 2023 )-Revenue per Share (A: Aug. 2022 ))/ | Revenue per Share (A: Aug. 2022 ) |
=(0.006-0)/ | 0 |
=N/A %

Lobe Sciences's YoY Rev. per Sh. Growth for the quarter that ended in May. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: May. 2024 )
=(Revenue per Share (Q: May. 2024 )-Revenue per Share (Q: May. 2023 )) / | Revenue per Share (Q: May. 2023 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
XCNQ:AION XCNQ:LOWL XCNQ:HERB TSXV:ENTG XCNQ:VIBE XCNQ:BCBC XCNQ:THC XCNQ:BBM TSXV:HMPG XCNQ:AYUR ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
6YX0:Germany LOBE:Canada
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Website
https://www.lobesciences.com
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.